Valuation: Highnoon Laboratories Limited

Market Cap 48.22B 174M 151M 142M 129M 242M 16.68B 244M 1.7B 657M 8.46B 653M 639M 26.97B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 48.22B 174M 151M 142M 129M 242M 16.68B 244M 1.7B 657M 8.46B 653M 639M 26.97B EV / Sales 2026 *
1.59x
EV / Sales 2027 * 1.41x
Free-Float
50.02%
Yield 2026 *
4.94%
Yield 2027 * 5.71%
1 day+0.15%
1 week-1.52%
Current month-2.65%
1 month-9.31%
3 months-8.17%
6 months+1.24%
Current year-10.99%
1 week 905
Extreme 905
936
1 month 905
Extreme 905
1,010
Current year 755.56
Extreme 755.56
1,101
1 year 755.56
Extreme 755.56
1,224
3 years 330
Extreme 330
1,241
5 years 322.1
Extreme 322.1
1,241
10 years 127.86
Extreme 127.855793
1,241
Manager TitleAgeSince
Chief Executive Officer - 01/04/2015
Chief Executive Officer 63 01/01/1996
Director of Finance/CFO - 01/04/2020
Director TitleAgeSince
Chairman - 07/09/2012
Chairman - -
Director/Board Member 36 -
Change 5-day change 1-year change 3-year change Capi.($)
+0.15%-1.52%-20.81%+169.69% 174M
+0.15%+1.21%+48.79%+99.17% 1,013B
+0.03%+0.07%+51.47%+64.51% 644B
-0.20%+4.62%+21.39%+70.53% 465B
+0.53%+3.42%+39.21%+38.70% 352B
+0.39%+2.22%+17.02%+23.87% 264B
+0.17%+2.19%+6.33%+10.93% 253B
+0.19%-3.81%+37.81%+43.02% 203B
-1.20%-6.64%-23.23%-59.10% 188B
+0.94%+1.39%+33.21%+95.29% 181B
Average +0.22%-0.99%+21.12%+55.66% 356.39B
Weighted average by Cap. +0.33%+0.01%+34.15%+59.58%

Financials

2026 *2027 *
Net sales 30.4B 110M 95.01M 89.8M 81.53M 153M 10.52B 154M 1.07B 414M 5.33B 412M 403M 17B 34.16B 123M 107M 101M 91.62M 172M 11.82B 173M 1.2B 466M 6B 463M 453M 19.11B
Net income - -
Net Debt - -
Logo Highnoon Laboratories Limited
Highnoon Laboratories Limited is a Pakistan-based company that is engaged in the manufacturing, importing, selling, and marketing of pharmaceutical and related consumer products. Its product categories include cardiology, metabolic, gastroenterology, musculoskeletal, anti-infective, obstetrics and gynecology, pediatrics, allergy, respiratory, and urology. Its cardiology products include Cuziper, Hitica, Apiban, Misar, and Herbesser. Its metabolic products include Daploz, Tagip, Diajard, and Nylomet. Its gastroenterology products include Rabecid, Racedo, Skilax, and Fosbu. Its musculoskeletal products include Kydor, Hilin, Airtal, and Tamadol. Its anti-infective products include Evacef, Maxum, Efix, and Cefia. Its obstetrics and gynecology products include Hitase. Its pediatrics product includes Tres Orix Forte. Its allergy products include Leviva and Kestine. Its respiratory products include Combivair Forte, Glynvair, Betatec, Ultivair, and Montit. Its urology products include Prostam.
Employees
2,563
Date Price Change Volume
16/09/26 PKR 910.09 +0.15% 4,860
15/09/26 PKR 908.77 -1.38% 18,139
14/09/26 PKR 921.48 -0.34% 3,568
11/09/26 PKR 924.60 +1.50% 10,529
10/09/26 PKR 910.96 -0.31% 11,688
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
910.09PKR
Average target price
1,121.00PKR
Spread / Average Target
+23.17%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. HINOON Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!